Angioplasty Balloons Market Report 2026

Angioplasty Balloons Market Overview

• Angioplasty Balloons market size has reached to $2.85 billion in 2025 • Expected to grow to $3.47 billion in 2030 at a compound annual growth rate (CAGR) of 3.9% • Growth Driver: Rising Cardiovascular Disease Rates Fuel Angioplasty Balloon Market Growth • Market Trend: Innovative System Enhances Precision In Manufacturing High-Pressure Medical Balloons • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Angioplasty Balloons Market?

Angioplasty balloons refer to medical devices used to open narrowed or blocked blood vessels in the body. These balloons are commonly employed in the treatment of conditions such as coronary artery disease and peripheral artery disease. It works by inflating within the artery to compress the plaque against the vessel wall, restoring blood flow. The main product types of angioplasty balloons are normal balloons, scoring balloons, drug-eluting balloons, and cutting balloons. Normal balloons refer to basic angioplasty devices without specialized features, designed to dilate narrowed or blocked blood vessels by inflation. The various materials include non-compliant, and semi-compliant. These are used in various applications such as coronary angioplasty, and peripheral angioplasty and also by various end users such as hospitals, specialty clinics, catheterization laboratories, ambulatory surgical centers, and others.

What Is The Angioplasty Balloons Market Growth Forecast?

The angioplasty balloons market size is expected to see steady growth in the next few years. It will grow to $3.47 billion in 2030 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to rising demand for drug-eluting and specialty balloons, increasing procedural volume in peripheral angioplasty, growth in complex lesion treatment requiring scoring and cutting balloons, expanding adoption of minimally invasive cardiovascular therapies, increasing investments in interventional cardiology infrastructure. Major trends in the forecast period include increasing adoption of drug-eluting balloons for complex coronary and peripheral lesions, rising utilization of non-compliant and semi-compliant balloons to enhance procedural precision, growing preference for scoring and cutting balloons in resistant and calcified stenoses, expansion of minimally invasive angioplasty interventions across cardiology and vascular care, increasing clinical shift toward balloon-based revascularization in patients unsuitable for stenting .

Global Angioplasty Balloons Market Segmentation

1) By Product Type: Normal Balloons, Scoring Balloons, Drug-Eluting Balloons, Cutting Balloons 2) By Material: Non-Compliant, Semi-Compliant 3) By Application: Coronary Angioplasty, Peripheral Angioplasty 4) By End User: Hospitals, Specialty Clinics, Catheterization Laboratories, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Normal Balloons: Non-Compliant Balloons, Compliant Balloons 2) By Scoring Balloons: Semi-Compliant Scoring Balloons, Non-Compliant Scoring Balloons 3) By Drug-Eluting Balloons: Paclitaxel-Eluting Balloons, Sirolimus-Eluting Balloons, Everolimus-Eluting Balloons 4) By Cutting Balloons: Balloon Catheters With Cutting Blades, Balloon Catheters With Radial Scoring Elements

What Is The Driver Of The Angioplasty Balloons Market?

The increasing incidence of cardiovascular diseases is expected to propel the angioplasty balloons market going forward. Cardiovascular disease refers to a group of conditions affecting the heart and blood vessels, often leading to complications such as heart attacks or strokes. Cardiovascular disease is on the rise due to sedentary lifestyles, unhealthy dietary habits, rising obesity rates, and aging populations. The angioplasty balloons are utilized in cardiovascular disease to widen narrowed or blocked blood vessels, restoring proper blood flow and reducing the risk of complications such as heart attacks or strokes. For instance, in September 2024, according to the data published by the Minnesota Department of Health, a US-based state health agency, approximately 30% of adults in Minnesota reported having high blood pressure in 2023, totaling nearly 1.4 million people, and in 2022, hypertensive diseases were the underlying or contributing cause of death for 14,225 residents, representing almost 28% of all deaths in the state. Therefore, the increasing incidence of cardiovascular diseases drives the growth of the angioplasty balloons industry.

Key Players In The Global Angioplasty Balloons Market

Major companies operating in the angioplasty balloons market are Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Cook Medical, Biotronik SE, Merit Medical Systems Inc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AngioDynamics, Cordis, iVascular, Hexacath, Balton Sp, Cardionovum, QualiMed Innovative Medizinprodukte GmbH, Translumina GmbH, Concept Medical Inc

Global Angioplasty Balloons Market Trends and Insights

Major companies operating in the angioplasty balloons market are focusing on developing innovative products, such as advanced medical balloon forming systems, to enhance precision in manufacturing high-pressure balloons for critical cardiac procedures. The Advanced Medical Balloon Forming System is a technology for precisely manufacturing compliant medical balloons used in catheter systems. For instance, in June 2024, Interface Catheter Solutions, a US-based, innovative catheter technology company, launched the BFM-5510 High Force Balloon Forming Machine. This advanced benchtop system is engineered for the production of low- and non-compliant polymer balloons utilized in angioplasty, stent placement, and other essential cardiac procedures. Building on the BFM-3310 platform, the BFM-5510 HF employs beryllium copper molds to precisely shape extruded balloon tubing, ensuring stringent quality and tight tolerances across a wide variety of sizes and shapes. This machine offers enhanced production capabilities to accommodate the demands of larger, thicker, and more complex medical balloon manufacturing.

What Are Latest Mergers And Acquisitions In The Angioplasty Balloons Market?

In September 2024, Quasar Medical, a US-based contract design and manufacturing organization, acquired Ridgeback Technologies for an undisclosed amount. The acquisition aims to strengthen Quasar Medical’s balloon catheter development and manufacturing capability by integrating Ridgeback Technologies’ expert design services, balloon fabrication technologies and Galway production facility, thereby accelerating time-to-market for complex catheter and angioplasty balloon programs. Ridgeback Technologies is an Ireland-based company specializing in the development and manufacture of advanced balloon catheters, including folded, perfusion and structural-heart balloons.

Regional Outlook

North America was the largest region in the angioplasty balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Angioplasty Balloons Market?

The angioplasty balloons market consists of sales of rapid exchange balloons, drug-eluting stent balloons, and microcatheter-compatible balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.